Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. 2003

Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
Department of Oral Medicine, Pathology & Immunology, GKT Dental Institute, Kings College London, London, United Kingdom. julian.naglik@kcl.ac.uk

Candida albicans is the most common fungal pathogen of humans and has developed an extensive repertoire of putative virulence mechanisms that allows successful colonization and infection of the host under suitable predisposing conditions. Extracellular proteolytic activity plays a central role in Candida pathogenicity and is produced by a family of 10 secreted aspartyl proteinases (Sap proteins). Although the consequences of proteinase secretion during human infections is not precisely known, in vitro, animal, and human studies have implicated the proteinases in C. albicans virulence in one of the following seven ways: (i) correlation between Sap production in vitro and Candida virulence, (ii) degradation of human proteins and structural analysis in determining Sap substrate specificity, (iii) association of Sap production with other virulence processes of C. albicans, (iv) Sap protein production and Sap immune responses in animal and human infections, (v) SAP gene expression during Candida infections, (vi) modulation of C. albicans virulence by aspartyl proteinase inhibitors, and (vii) the use of SAP-disrupted mutants to analyze C. albicans virulence. Sap proteins fulfill a number of specialized functions during the infective process, which include the simple role of digesting molecules for nutrient acquisition, digesting or distorting host cell membranes to facilitate adhesion and tissue invasion, and digesting cells and molecules of the host immune system to avoid or resist antimicrobial attack by the host. We have critically discussed the data relevant to each of these seven criteria, with specific emphasis on how this proteinase family could contribute to Candida virulence and pathogenesis.

UI MeSH Term Description Entries
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D005656 Fungal Proteins Proteins found in any species of fungus. Fungal Gene Products,Fungal Gene Proteins,Fungal Peptides,Gene Products, Fungal,Yeast Proteins,Gene Proteins, Fungal,Peptides, Fungal,Proteins, Fungal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D016282 Aspartic Acid Endopeptidases A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity. Aspartic Endopeptidases,Aspartyl Endopeptidases,Acid Endopeptidases, Aspartic,Endopeptidases, Aspartic Acid,Endopeptidases, Aspartyl

Related Publications

Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
December 1996, Current topics in medical mycology,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
November 2008, Microbiology (Reading, England),
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
October 1993, Journal of bacteriology,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
August 2007, Investigative ophthalmology & visual science,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
January 2002, Chemical immunology,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
June 1998, Infection and immunity,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
June 2014, International journal of molecular sciences,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
March 2003, Journal of medical microbiology,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
February 2016, Journal of prosthodontics : official journal of the American College of Prosthodontists,
Julian R Naglik, and Stephen J Challacombe, and Bernhard Hube
March 2014, Journal of biomedical science,
Copied contents to your clipboard!